Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease

Journal of Hand Surgery

Volumn 27, Issue 5, 2002, Pages 788-798

  Badalamente, Marie A ^a,b   Hurst, Lawrence C ^a,b   Brook, Stony ^a,b   Hentz, Vincent R ^a,b   Alto, Palo ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Collagenase injection; Dupuytren's disease

Indexed keywords

BACTERIAL ENZYME; COLLAGEN; COLLAGENASE; DIPHENHYDRAMINE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DUPUYTREN CONTRACTURE; ENZYME THERAPY; FASCIA; FEMALE; FINGER; FOOD AND DRUG ADMINISTRATION; HUMAN; INJECTION PAIN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; UNITED STATES; URTICARIA;

EID: 0036738805     PISSN: 03635023     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhsu.2002.35299     Document Type: Article

References (28)

1. Plater F. Observationes in hominis affectibus. vol. 3. Basel: Konig and Bradmyller, 1614:140.
2. Gabbiani G, Majno G. Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol 1972;66:131-146.
3. Tomasek JJ, Schultz RJ, Haaksma CJ. Extracellular matrix-cytoskeleton connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease. J Bone Joint Surg 1987;69A:1400-1407.
4. Tomasek JJ, Haaksma CJ. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue. Anat Rec 1991;230:175-182.
5. Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg 1981;63A:787-797.
6. Badalamente MA, Hurst LC, Sampson SP. Prostaglandins influence myofibroblast contractility in Dupuytren's disease. J Hand Surg 1988;13A:867-871.
7. Hurst LC, Badalamente MA, Makowski J. The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts. J Hand Surg 1986;11A:18-23.
8. Badalamente MA, Hurst LC, Grandia SK, Sampson SP. Platelet-derived growth factor in Dupuytren's disease. J Hand Surg 1992;17A:317-323.
9. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor beta in Dupuytren's disease. J Hand Surg 1996;21A:210-215.
10. Alioto RJ, Rosier RN, Burton RI, Puzas JE. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. J Hand Surg 1994;19A:442-452.
11. Badalamente MA, Stern L, Hurst LC. The pathogenesis of Dupuytren's contracture: contractile mechanisms of the myofibroblasts. J Hand Surg 1983;8:235-243.
12. Dahmen G, Kerckhoff F. Possibilities and limitations of the conservative treatment of Dupuytren's contracture. Med Monatsschr. 1966;20:297-300.
13. Dominguez-Malagon HR, Alferian-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478-2483.
14. Falter E, Herndl E, Muhlbauer W. Dupuytren's contracture. When operate? Conservative preliminary treatment? Fortschr Med 1991;109:223-226.
15. Howard L, Pratt D, Bunnelli S. The use of compound F (hydrocortone) in operative and nonoperative conditions of the hand. J Bone Joint Surg 1953;35A:994-1002.
16. Keilholz L, Seegenschmiedt MH, Sauer R. Radiotherapy for prevention of disease progression in early-stage Dupuytren's contracture: initial and long-term results. Int J Radiat Oncol Biol Phys 1996;36:891-897.
17. Kirk J, Chieffi MN. Tocopherol administration to patients with Dupuytren's contracture: effect on plasma tocopherol levels and degree of contracture. Proc Soc Exp Biol Med 1952;80:321-324.
18. Pittet B, Rubbia-Brandt L, Desmouliere A, Sappino AP, Roggero P, Guerret S, et al. Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg 1994;93:1224-1235.
19. Stiles PJ. Ultrasonic therapy in Dupuytren's contracture. J Bone Joint Surg 1966;48B:452-454.
20. Vuopala U, Kaipainen W. DMOS in the treatment of Dupuytren's contracture. A therapeutic experiment. Acta Rheum Scand 1971;17:61-62.
21. Weinzierl G, Flugel M, Geldmacher J. Lack of effectiveness of alternative non-surgical treatment procedures of Dupuytren contracture. Chirurg 1993;64:492-494.
22. Hakstian RW. Late results of extensive fasciectomy. In: Hueston J, Tubiana R, eds. Dupuytren's disease. Edinburgh: Churchill Livingstone, 1974:79-83.
23. McFarlane R, Botz JS, Cheung H. Epidemiology of surgical patients. In: McFarlane RM, McGrouther DA, Flint MH, eds. Dupuytren's Disease. Edinburgh: Churchill Livingstone, 1990:201-238.
24. Hueston JT. Enzymtic fasciotomy. Hand 1971;3:38-40.
25. McCarthy DM. The long-term results of enzymic fasciotomy. J Hand Surg 1992;17B:356.
26. Starkweather KD, Lattuga S, Hurst LC, Badalamente MA, Guilak F, Sampson SP, Dowd A. Collagenase in the treatment of Dupuytren's disease: an in vitro study. J Hand Surg 1996;21A:490-495.
27. Badalamente MA, Hurst LC. Enzyme injection as a nonoperative treatment for Dupuytren's disease. Drug Delivery 1996;3:35-40.
28. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg 2000;25A:629-636.